A Study to Assess the Safety and Efficacy of AF-130 in the Treatment of Uncontrolled Hypertension in Subjects with Overactive Carotid Body Drive
Latest Information Update: 14 Jul 2016
At a glance
- Drugs AF 130 (Primary)
- Indications Hypertension
- Focus Proof of concept; Therapeutic Use
- Sponsors Afferent Pharmaceuticals
- 25 May 2016 New trial record